Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir

Prevalence of chronic hepatitis C (CH-C) infection in patients of Asian ancestry ranges between 1% and 20%. Interferon (IFN)- and ribavirin (RBV)-containing regimens for CH-C have a negative impact on patient-reported outcomes (PROs) during treatment. The aim of this study was to assess the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Younossi, Zobair M., Stepanova, Maria, Chan, Henry L.Y., Lee, Mei H., Yu, Ming-Lung, Dan, Yock Y., Choi, Moon S., Henry, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782840/
https://www.ncbi.nlm.nih.gov/pubmed/26945356
http://dx.doi.org/10.1097/MD.0000000000002702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782840/
https://www.ncbi.nlm.nih.gov/pubmed/26945356
http://dx.doi.org/10.1097/MD.0000000000002702

Ejemplares similares